Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1967 2
1968 1
1974 2
1977 1
1978 1
1979 1
1980 2
1981 2
1982 2
1983 1
1984 1
1985 3
1986 1
1987 3
1988 6
1989 3
1990 5
1991 1
1992 2
1994 4
1995 5
1996 4
1997 3
1998 7
1999 3
2000 7
2001 6
2002 5
2003 5
2004 5
2005 7
2006 6
2007 8
2008 10
2009 8
2010 18
2011 13
2012 13
2013 15
2014 7
2015 8
2016 18
2017 17
2018 13
2019 10
2020 21
2021 15
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

272 results
Results by year
Filters applied: . Clear all
Page 1
Phase I/II study of tirabrutinib, a second-generation Bruton's tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma.
Narita Y, Nagane M, Mishima K, Terui Y, Arakawa Y, Yonezawa H, Asai K, Fukuhara N, Sugiyama K, Shinojima N, Kitagawa J, Aoi A, Nishikawa R. Narita Y, et al. Among authors: terui y. Neuro Oncol. 2021 Jan 30;23(1):122-133. doi: 10.1093/neuonc/noaa145. Neuro Oncol. 2021. PMID: 32583848 Free PMC article. Clinical Trial.
A multicenter, open-label, phase II study of tirabrutinib (ONO/GS-4059) in patients with Waldenstr├Âm's macroglobulinemia.
Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Shiibashi R, Izutsu K. Sekiguchi N, et al. Among authors: terui y. Cancer Sci. 2020 Sep;111(9):3327-3337. doi: 10.1111/cas.14561. Epub 2020 Jul 20. Cancer Sci. 2020. PMID: 32639651 Free PMC article. Clinical Trial.
[Cytidine].
Terui Y. Terui Y. Nihon Rinsho. 2015 Feb;73 Suppl 2:159-61. Nihon Rinsho. 2015. PMID: 25831743 Japanese. No abstract available.
[CD20].
Terui Y. Terui Y. Nihon Rinsho. 2012 Nov;70 Suppl 8:170-5. Nihon Rinsho. 2012. PMID: 23513833 Japanese. No abstract available.
[Proteasome inhibitors].
Hatake K, Mishima Y, Terui Y. Hatake K, et al. Among authors: terui y. Gan To Kagaku Ryoho. 2004 Jul;31(7):999-1002. Gan To Kagaku Ryoho. 2004. PMID: 15272575 Review. Japanese.
Polyamines protect nucleic acids against depurination.
Terui Y, Yoshida T, Sakamoto A, Saito D, Oshima T, Kawazoe M, Yokoyama S, Igarashi K, Kashiwagi K. Terui Y, et al. Int J Biochem Cell Biol. 2018 Jun;99:147-153. doi: 10.1016/j.biocel.2018.04.008. Epub 2018 Apr 9. Int J Biochem Cell Biol. 2018. PMID: 29649565
[Resistance to rituximab and CD20 mutation].
Terui Y, Hatake K. Terui Y, et al. Nihon Rinsho. 2007 Jan 28;65 Suppl 1:416-23. Nihon Rinsho. 2007. PMID: 17474440 Review. Japanese. No abstract available.
Impact of Omission/Reduction of Vincristine From R-CHOP in Treatment of DLBCL.
Marshall S, Nishimura N, Inoue N, Yamauchi H, Tsuyama N, Takeuchi K, Mishima Y, Yokoyama M, Ogasawara T, Mori N, Ogawa T, Sakura H, Terui Y. Marshall S, et al. Among authors: terui y. Clin Lymphoma Myeloma Leuk. 2021 Mar;21(3):162-169. doi: 10.1016/j.clml.2020.12.017. Epub 2020 Dec 23. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33483276 Free article.
272 results